This report contains market size and forecasts of Conjugate Vaccine in global, including the following market information:
Global Conjugate Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Conjugate Vaccine Market Sales, 2016-2021, 2022-2027, (Million Unit)
Global top five Conjugate Vaccine companies in 2020 (%)
The global Conjugate Vaccine market was valued at 9960.9 million in 2020 and is projected to reach US$ 11240 million by 2027, at a CAGR of 3.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Conjugate Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Conjugate Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, By Type, 2020 (%)
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Conjugate Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, By Application, 2020 (%)
Children
Adult
Global Conjugate Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Conjugate Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Conjugate Vaccine revenues share in global market, 2020 (%)
Key companies Conjugate Vaccine sales in global market, 2016-2021 (Estimated), (Million Unit)
Key companies Conjugate Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Conjugate Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End Users
1.3 Global Conjugate Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Conjugate Vaccine Overall Market Size
2.1 Global Conjugate Vaccine Market Size: 2021 VS 2027
2.2 Global Conjugate Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Conjugate Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Conjugate Vaccine Players in Global Market
3.2 Top Global Conjugate Vaccine Companies Ranked by Revenue
3.3 Global Conjugate Vaccine Revenue by Companies
3.4 Global Conjugate Vaccine Sales by Companies
3.5 Global Conjugate Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Conjugate Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Conjugate Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjugate Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Conjugate Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Conjugate Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Conjugate Vaccine Market Size Markets, 2021 & 2027
4.1.2 Hib Vaccine
4.1.3 Meningococcal Vaccine
4.1.4 Pneumococcal Vaccine
4.1.5 Others
4.2 By Type - Global Conjugate Vaccine Revenue & Forecasts
4.2.1 By Type - Global Conjugate Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Conjugate Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Conjugate Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Conjugate Vaccine Sales & Forecasts
4.3.1 By Type - Global Conjugate Vaccine Sales, 2016-2021
4.3.2 By Type - Global Conjugate Vaccine Sales, 2022-2027
4.3.3 By Type - Global Conjugate Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Conjugate Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Conjugate Vaccine Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Conjugate Vaccine Revenue & Forecasts
5.2.1 By Application - Global Conjugate Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Conjugate Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Conjugate Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Conjugate Vaccine Sales & Forecasts
5.3.1 By Application - Global Conjugate Vaccine Sales, 2016-2021
5.3.2 By Application - Global Conjugate Vaccine Sales, 2022-2027
5.3.3 By Application - Global Conjugate Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Conjugate Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Conjugate Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Conjugate Vaccine Revenue & Forecasts
6.2.1 By Region - Global Conjugate Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Conjugate Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Conjugate Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Conjugate Vaccine Sales & Forecasts
6.3.1 By Region - Global Conjugate Vaccine Sales, 2016-2021
6.3.2 By Region - Global Conjugate Vaccine Sales, 2022-2027
6.3.3 By Region - Global Conjugate Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Conjugate Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Conjugate Vaccine Sales, 2016-2027
6.4.3 US Conjugate Vaccine Market Size, 2016-2027
6.4.4 Canada Conjugate Vaccine Market Size, 2016-2027
6.4.5 Mexico Conjugate Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Conjugate Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Conjugate Vaccine Sales, 2016-2027
6.5.3 Germany Conjugate Vaccine Market Size, 2016-2027
6.5.4 France Conjugate Vaccine Market Size, 2016-2027
6.5.5 U.K. Conjugate Vaccine Market Size, 2016-2027
6.5.6 Italy Conjugate Vaccine Market Size, 2016-2027
6.5.7 Russia Conjugate Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Conjugate Vaccine Market Size, 2016-2027
6.5.9 Benelux Conjugate Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Conjugate Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Conjugate Vaccine Sales, 2016-2027
6.6.3 China Conjugate Vaccine Market Size, 2016-2027
6.6.4 Japan Conjugate Vaccine Market Size, 2016-2027
6.6.5 South Korea Conjugate Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Conjugate Vaccine Market Size, 2016-2027
6.6.7 India Conjugate Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Conjugate Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Conjugate Vaccine Sales, 2016-2027
6.7.3 Brazil Conjugate Vaccine Market Size, 2016-2027
6.7.4 Argentina Conjugate Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Conjugate Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Conjugate Vaccine Sales, 2016-2027
6.8.3 Turkey Conjugate Vaccine Market Size, 2016-2027
6.8.4 Israel Conjugate Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Conjugate Vaccine Market Size, 2016-2027
6.8.6 UAE Conjugate Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Conjugate Vaccine Major Product Offerings
7.1.4 Pfizer Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Conjugate Vaccine Major Product Offerings
7.2.4 GSK Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Conjugate Vaccine Major Product Offerings
7.3.4 Sanofi Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Conjugate Vaccine Major Product Offerings
7.4.4 Merck Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Corporate Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Conjugate Vaccine Major Product Offerings
7.5.4 Walvax Biotechnology Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Walvax Biotechnology Key News
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Major Product Offerings
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News
7.7 Bharat Biotech
7.7.1 Bharat Biotech Corporate Summary
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Conjugate Vaccine Major Product Offerings
7.4.4 Bharat Biotech Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Bharat Biotech Key News
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Corporate Summary
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Conjugate Vaccine Major Product Offerings
7.8.4 Zhifei Biologic Conjugate Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Zhifei Biologic Key News
8 Global Conjugate Vaccine Production Capacity, Analysis
8.1 Global Conjugate Vaccine Production Capacity, 2016-2027
8.2 Conjugate Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Conjugate Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Conjugate Vaccine Supply Chain Analysis
10.1 Conjugate Vaccine Industry Value Chain
10.2 Conjugate Vaccine Upstream Market
10.3 Conjugate Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Conjugate Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Conjugate Vaccine in Global Market
Table 2. Top Conjugate Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Conjugate Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Conjugate Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Conjugate Vaccine Sales by Companies, (Million Unit), 2016-2021
Table 6. Global Conjugate Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Conjugate Vaccine Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Conjugate Vaccine Product Type
Table 9. List of Global Tier 1 Conjugate Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Conjugate Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type